What are the risks of malignancies due to having IBD and being on immunomodulators and/or biologics: How can we help our patients avoid those risks?

08/07/2018

Related Content

Psychiatry
Psychiatry
Jordan Grumet, MD, on Preview: The Intimacy Gap and Shared Storytelling
11/30/2019
In this video, Jordan Grumet, MD, gives a preview of his presentation on how practitioners can break the intimacy gap between providers and patients, which will be presented at the Practical Updates in...
11/30/2019
Treatment
Treatment
Treating HCV: What’s Coming Up the Therapeutic Pipeline?
04/09/2015
David R. Nelson, MD, discusses future developments to HCV treatment strategies and methods, and how they will affect the standard of care.
04/09/2015
Pediatric Gastroenterology
Daniel von Allmen, MD
Pediatric Gastroenterology
Daniel von Allmen, MD, on When to Consider Surgery in Pediatric Inflammatory Bowel Disease
07/16/2010
In this video, Daniel von Allmen, MD, from Cincinnati Children's Hospital, discusses when a clinician should consider surgery over systemic therapy for the treatment of pediatric inflammatory bowel...
07/16/2010
Gastroenterology
Gastroenterology
AIBD2016_CLINICAL_06_melmed
08/01/2018
08/01/2018
Stress and Burnout
Stress and Burnout
Elizabeth Volkmann, MD, MS, on How I Practice Now: Using a Multidisciplinary Approach to Managing Autoimmune Disease
07/14/2020
In this video, Elizabeth Volkmann, MD, MS, talks about her experience with managing autoimmune disease during the COVID-19 pandemic, as well as her hopes for the use of telemedicine in the future.
07/14/2020